Literature DB >> 24121257

Aspiration and allograft injury secondary to gastroesophageal reflux occur in the immediate post-lung transplantation period (prospective clinical trial).

S Michael Griffin1, Andrew G N Robertson, Albert J Bredenoord, Iain A Brownlee, Rachel Stovold, Malcolm Brodlie, Ian Forrest, John H Dark, Jeff P Pearson, Chris Ward.   

Abstract

OBJECTIVES: To provide novel pilot data to quantify reflux, aspiration, and allograft injury immediately post-lung transplantation.
BACKGROUND: Asymptomatic reflux/aspiration, associated with allograft dysfunction, occurs in lung transplant recipients. Early fundoplication has been advocated. Indications for surgery include elevated biomarkers of aspiration (bile salts) in bronchoalveolar lavage fluid (BALF). Measurements have been mostly documented after the immediate posttransplant period. We report the first prospective study of reflux/aspiration immediately posttransplantation to date.
METHODS: Lung transplant recipients were recruited over 12 months. At 1 month posttransplantation, patients completed a Reflux Symptom Index questionnaire and underwent objective assessment for reflux (manometry and pH/impedance). Testing was performed on maintenance proton pump inhibitor. BALF was assessed for pepsin, bile salts, interleukin-8 and neutrophils.
RESULTS: Eighteen lung transplant recipients, median age of 46 years (range: 22-59 years), were recruited. Eight of 18 patients had abnormal esophageal peristalsis. Five of 17 patients were positive on Reflux Symptom Index questionnaire. Twelve of 17 patients had reflux. Three patients exclusively had weakly acid reflux. Median acid exposure was 4.8% (range: 1%-79.9%) and median esophageal volume exposure was 1.6% (range: 0.7-5.5). There was a median of 72 reflux events (range: 27-147) per 24 hours. A correlation existed between Reflux Symptom Index score and proximal reflux (r = 0.533, P = 0.006). Pepsin was detected in 11 of 15 BALF samples signifying aspiration (median: 18 ng/mL; range: 0-43). Bile salts were undetectable, using spectrophotometry and rarely detectable using dual mass spectrometry (2/15) (levels 0.2 and 1.2 μmol/L). Lavage interleukin-8 and neutrophil levels were elevated. A correlation existed between proximal reflux events and neutrophilia (r = 0.52, P = 0.03).
CONCLUSIONS: Lung transplant recipients should be routinely assessed for reflux/aspiration within the first month posttransplant. Reflux/aspiration can be present early postoperatively. Pepsin was detected suggesting aspiration. Bile salts were rarely detected. Proximal reflux events correlated with neutrophilia, linked to allograft dysfunction and mortality. These results support the need for early assessment of reflux/aspiration, which may inform fundoplication.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24121257     DOI: 10.1097/SLA.0b013e3182a6589b

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  13 in total

1.  Tap Water Avoidance Decreases Rates of Hospital-onset Pulmonary Nontuberculous Mycobacteria.

Authors:  Arthur W Baker; Jason E Stout; Deverick J Anderson; Daniel J Sexton; Becky Smith; Rebekah W Moehring; Kirk Huslage; Christopher J Hostler; Sarah S Lewis
Journal:  Clin Infect Dis       Date:  2021-08-02       Impact factor: 9.079

Review 2.  Esophageal Dysfunction in Post-lung Transplant: An Enigma.

Authors:  Aditya V Jadcherla; Kevin Litzenberg; Gokulakrishnan Balasubramanian
Journal:  Dysphagia       Date:  2022-08-12       Impact factor: 2.733

3.  Bronchoalveolar bile acid and inflammatory markers to identify high-risk lung transplant recipients with reflux and microaspiration.

Authors:  Chen Yang Kevin Zhang; Musawir Ahmed; Ella Huszti; Liran Levy; Sarah E Hunter; Kristen M Boonstra; Sajad Moshkelgosha; Andrew T Sage; Sassan Azad; Ricardo Zamel; Rasheed Ghany; Jonathan C Yeung; Oscar M Crespin; Courtney Frankel; Marie Budev; Pali Shah; John M Reynolds; Laurie D Snyder; John A Belperio; Lianne G Singer; S Samuel Weigt; Jamie L Todd; Scott M Palmer; Shaf Keshavjee; Tereza Martinu
Journal:  J Heart Lung Transplant       Date:  2020-05-19       Impact factor: 10.247

4.  Successful surgical management of early esophageal cancer in a patient with cystic fibrosis post-bilateral lung transplantation.

Authors:  Siun M Walsh; Nomsa Maphango; Jim J Egan; John V Reynolds
Journal:  BMJ Case Rep       Date:  2015-11-03

Review 5.  Minor esophageal functional disorders: are they relevant?

Authors:  Ryan A Balko; Don C Codipilly; Karthik Ravi
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-17

6.  Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation.

Authors:  Arthur W Baker; Sarah S Lewis; Barbara D Alexander; Luke F Chen; Richard J Wallace; Barbara A Brown-Elliott; Pamela J Isaacs; Lisa C Pickett; Chetan B Patel; Peter K Smith; John M Reynolds; Jill Engel; Cameron R Wolfe; Carmelo A Milano; Jacob N Schroder; Robert D Davis; Matthew G Hartwig; Jason E Stout; Nancy Strittholt; Eileen K Maziarz; Jennifer Horan Saullo; Kevin C Hazen; Richard J Walczak; Ravikiran Vasireddy; Sruthi Vasireddy; Celeste M McKnight; Deverick J Anderson; Daniel J Sexton
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079

7.  A randomised controlled trial of azithromycin therapy in bronchiolitis obliterans syndrome (BOS) post lung transplantation.

Authors:  Paul A Corris; Victoria A Ryan; Therese Small; James Lordan; Andrew J Fisher; Gerard Meachery; Gail Johnson; Chris Ward
Journal:  Thorax       Date:  2015-02-24       Impact factor: 9.139

8.  Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.

Authors:  Gemma L Zeybel; Jeffrey P Pearson; Amaran Krishnan; Stephen J Bourke; Simon Doe; Alan Anderson; Shoaib Faruqi; Alyn H Morice; Rhys Jones; Melissa McDonnell; Mujdat Zeybel; Peter W Dettmar; Malcolm Brodlie; Chris Ward
Journal:  J Cyst Fibros       Date:  2016-07-27       Impact factor: 5.482

Review 9.  An update on current treatment strategies for managing bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Ashwini Arjuna; Michael T Olson; Rajat Walia; Ross M Bremner; Michael A Smith; Thalachallour Mohanakumar
Journal:  Expert Rev Respir Med       Date:  2020-10-25       Impact factor: 3.772

10.  Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients.

Authors:  H Al-Momani; A Perry; C J Stewart; R Jones; A Krishnan; A G Robertson; S Bourke; S Doe; S P Cummings; A Anderson; T Forrest; S M Griffin; M Brodlie; J Pearson; C Ward
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.